Making life-saving medicine more affordable
PlantForm Corporation is a Canadian biotech company with an innovative, low-cost manufacturing system for a wide range of plant-made pharmaceuticals.
Our patented molecular farming platform, vivoXPRESS®, uses tobacco plants to produce high quality monoclonal antibodies and therapeutic proteins for the treatment of cancer, HIV/AIDS and other devastating diseases. With production costs approximately one-tenth of the cost of mammalian-cell systems, vivoXPRESS® is our solution to the rapidly rising global demand for more affordable biopharmaceuticals.
PlantForm's pipeline includes:
three biosimilar cancer drugs, leading with biosimilar Herceptin® (trastuzumab) for breast cancer
an innovator antibody for treatment of ricin exposure
innovator antibodies for HIV/AIDS (R&D funded by the Gates Foundation and the Government of Canada)
innovator antibodies for treatment of Ebola virus (Sudan strain)
recombinant butyrylcholinesterase (BuChE) for protection against nerve agent exposure
Site Design by RKD Web Studios